Replies to post #96900 on Biotech Values

[genisi]

Teva’s low-volume formulation will be a new branded drug, separate from regular Copaxone

What if the new low-volume formulation will be Teva's only version in the market (I assume Teva will switch patients and then withdraw the old product from the market).